Advanced research breakthroughs and integration of advanced technologies for predicting and analyzing the development and progression of diseases have allowed the diagnostics and research industry to grow significantly over the past few years. Rising investments in the industry make its long-term prospects bright. The clinical diagnostics market is expected to grow at a 6.1% CAGR to reach $93.85 billion by 2026.
Thermo Fisher Scientific Inc. (TMO) and Danaher Corporation (DHR) are two prominent companies in the global diagnostics and research sector. TMO offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and services. It serves pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies. In comparison, DHR designs, manufactures, and markets professional, medical, industrial, and commercial products and services in test and measurement, environmental, life sciences, dental, and industrial technologies.
